The symptoms of Hepatocellular carcinoma include:
- Sudden loss of weight
- Poor appetite
- Pain in the upper parts of the abdomen.
- Feeling of nausea and vomiting
- Weakness and fatigue
- Swelling in the abdomen
- Pale coloured stools
Hepatocellular carcinoma is a condition that commonly arises in patients who are diagnosed with chronic liver diseases such as acute liver failure. Hepatocellular carcinoma is the most common kind of primary liver cancer. Primary cancers like Hepatocellular carcinoma originate from the patient’s liver itself.
The causes of Hepatocellular carcinoma are often unclear in some cases. However, in certain cases, it may develop due to chronic infection which is caused by the hepatitis virus. The disease may even develop due to certain abnormalities in the liver cells when they go through mutations. These clusters of cells may turn into a cancerous tumour.
The doctor may try to control the symptoms and the complications of Hepatocellular carcinoma through medication or through surgical procedures...
The doctor may try to control the symptoms and the complications of Hepatocellular carcinoma through medication or through surgical procedures.
The doctor conducts a surgery to remove the cancer from the patient’s liver.
The doctor may opt for a liver transplant surgery in which he will remove the diseased liver and replace it with a healthy liver donated by another person.
Cancer cells in the liver can be destroyed completely by subjecting them to extremely hot or cold conditions.
In the procedure, the chemotherapy drugs are delivered to the liver with the help of a catheter.
The doctor conducts a radiation therapy when a surgery can’t be conducted to treat the disease.
The patient should be closely monitored for symptoms of Hepatocellular carcinoma. One should consult the doctor as soon as they start noticing any signs or symptoms of the disease in a person. The appropriate treatment and the associated side effects should be thoroughly evaluated and discussed with the doctor.
Medanta ensures expert care for its patients who are diagnosed with Hepatocellular carcinoma at the Institute of Liver Transplantation and Regenerative Medicine. The Medanta Institute of Liver Transplantation and Regenerative Medicine is Asia’s ..
Medanta ensures expert care for its patients who are diagnosed with Hepatocellular carcinoma at the Institute of Liver Transplantation and Regenerative Medicine. The Medanta Institute of Liver Transplantation and Regenerative Medicine is Asia’s first of its kind dedicated Institute offering liver transplantation and all other levels of treatment for liver and biliary diseases including cancer, both in adults and children. The Living Donor Liver Transplant program is the largest in India and second largest in the world with a team of highly qualified doctors with a rich experience of more than 2500 Liver Transplants, having groomed the programme from its inception. The program has achieved the highest success rates (95%) and lowest infection rates (<10%) in Liver Transplant. The Institute is also a high-volume referral centre for all types of liver tumours, bile duct cancer, cysts and blocks and all complex non-transplant liver and biliary surgery. The Institute is committed to a scientific, compassionate & a patient-friendly approach.
We love to hear about our doctors, facilities
and your treatment at Medanta.
The User agrees and acknowledges that the User has read, understood and accepts the terms and conditions contained in the brochure provided with the Device (“Device”) with respect to its usage, operations, return / replacement and warranty policy.
The User hereby agrees and acknowledges that the Device (hardware and software) used in the provision
of services by Medanta is being provided on “as is” and “as available” basis through Alivecor India Private
Limited. Neither does Medanta endorse or promote the Device in any manner nor will Medanta be liable
for any claims, representations or warranties, whether express or implied as to the safety, reliability,
durability and performance of the device.
The services once availed cannot be cancelled except in cases where the User requests to cancel the service on the day of purchase in which case, full amount of service fees shall be refunded to the User provided that the Device has not been unboxed.
Before the expiry of service duration, the User can extend the services by availing various program options. For the said purposes, the User can call our helpline number +91 124 4141414 or visit www.medanta.org. The extended program availed by the User shall be activated automatically on expiry of existing program of services.
In cases where the User has opted for availing the Services through rented Device, a refundable deposit amount of ₹ 5,000 (“Deposit Amount”) shall be applicable and paid by the User. The refund of Deposit Amount shall be subject to return of the Device in working and undamaged condition. Refund of Deposit Amount shall be made through the same mode of payment as that of purchase in cases where the User personally visits the Medanta for returning the Device. If the User opts to return the Device through post, Deposit Amount shall be refunded electronically thorough NEFT or Bank transfer by Medanta within seven (7) working days of receipt of the Device and receipt of scanned image/copy of the ‘Cancelled Cheque’ of the User’s bank account.
Upon expiry of the services (either in terms of number of ECG or duration of the program) availed by the
User, the Device has to be returned within ten (10) days failing which the Deposit Amount shall be
Please note that the ECG pack or Refundable Device deposit are non-transferable from one patient to another.